Cite
HARVARD Citation
Ampudia-Mesias, E. et al. (n.d.). IMMU-02. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT: A NEW DIRECTION FOR CHECKPOINT IMMUNOTHERAPY. Neuro-oncology. pp. iv27-iv28. [Online].